Organisation
Department of Pharmaceutics
Department
Current researchers
101 - 110 of 120 results
- Laurentijn Tilleman (Member)
- Julie Traen (Member)
- Serge Van Calenbergh (Member)
- Anouk Van Hauwermeiren (Member)
- Simon Van Herck (Member)
- Benedikt Van Nieuwenhove (Member)
- Filip Van Nieuwerburgh (Member)
- Bart Van Puyvelde (Member)
- Ewout Van de Velde (Member)
- Valérie Vanhoorne (Member)
Projects
101 - 110 of 375
- Epic Proteomics: an MS-based workflow for parallel profiling of histone epigenetics and protein expression.From1 Oct 2021 → TodayFunding: BOF - doctoral mandates
- Nanopore sequencing of complete pharmacogenes after CRISPR/Cas9 enrichment in tamoxifen and clopidogrel patients allowing enhanced haplotyping and continuous scale machine learning efficacy prediction.From1 Oct 2021 → TodayFunding: BOF - doctoral mandates
- Extending the forensic toolbox: the use of Data-Independent Mass Spectrometry for forensic peptide marker discovery and MRM assay development.From1 Oct 2021 → TodayFunding: FWO junior postdoctoral fellowship
- IonKey/MSTM system: enhanced ‘plug and play’ mass spectrometry for ultrasensitive quantification of small molecules in small sample volumes in life sciences, with applications in the development and valorisation of endotoxin-mitigation strategies (feed additives) and anti-inflammatory drugs (pharma) in livestock.From1 Oct 2021 → 30 Sep 2023Funding: IOF - technology validation in lab
- Targeting transcription factor addiction in acute leukemia (TaTFAL)From1 Oct 2021 → TodayFunding: FWO Strategic Basic Research (SBO)
- A targeted nanomedicine strategy for in vivo CD8+ T cell engineeringFrom1 Oct 2021 → 31 Oct 2022Funding: BOF - doctoral mandates
- Normalising tumour pH to bring the STING back in anti-tumour immunityFrom1 Oct 2021 → TodayFunding: FWO junior postdoctoral fellowship
- Intraperitoneal Aerosolized Liposomal Irinotecan (NalIRI) in Peritoneal Carcinomatosis from GI cancer: a phase I firstinhuman studyFrom1 Aug 2021 → TodayFunding: Private funding of national origin - undefined
- BioGelator for local immunotherapyFrom15 Jul 2021 → TodayFunding: IOF - technology validation in lab
- An innovative class of ionizable lipids for use in lipid nanoparticle based RNA therapeutics and vaccinesFrom15 Jul 2021 → 14 Jul 2022Funding: IOF - technology concept exploration
Publications
1 - 10 of 1921
- Tailored design of sugar-modified a-GalCer analogues for Th1-polarized immune responses(2018)
Authors: Serge Van Calenbergh
Pages: 42 - 42 - Structural basis for the recognition of C20:2-U+03B1GalCer by the invariant natural killer T-cell receptor-like antibody L363(2012)
Authors: Esther Dawen Yu, Enrico Girardi, Jing Wang, Thien-Thi Mac Mac, Karl OA Yu, Serge Van Calenbergh, Steven A Porcelli, Dirk M Zajonc
Pages: 1269 - 1278 - Common genetic determinants of lung function, subclinical atherosclerosis and risk of coronary artery disease(2014)
Authors: Maria Sabater-Lleal, Aners Mälarstig, Lasse Folkersen, María Soler Artigas, Damiano Baldassarre, Maryam Kavousi, Peter Almgren, Fabrizio Veglia, Guy Brusselle, Albert Hofman, et al.
- Outpatient Pharmacotherapy(2008)
Authors: Guy Brusselle
Pages: 331 - 349 - Properties of the COPD assessment test in a cross-sectional European study(2011)
Authors: PW Jones, Guy Brusselle, RW Dal Negro, M Ferrer, P Kardos, ML Levye, T Perez, JJ Soler Cataluña, T van der Molen, L Adamek, et al.
Pages: 29 - 35 - Mechanistic links between COPD and lung cancer: a role of microRNA let-7?(2014)
Authors: Jae Il Shin, Guy Brusselle
Pages: 70 - 70 - Effect of a 3-month low-dose azithromycin intervention for COPD exacerbations requiring hospitalization on subsequent respiratory events and mortality : the BACE trial(2019)Volume: 199
Authors: W Janssens, K Vermeersch, T Troosters, Guy Brusselle
Number of pages: 1 - Disease-modifying anti-asthmatic drugs(2022)
Authors: Marek Lommatzsch, Guy Brusselle, G. Walter Canonica, David J. Jackson, Parameswaran Nair, Roland Buhl, Johann Christian Virchow
Pages: 1664 - 1668 - I have taken my umbrella, so of course it does not rain(2012)
Authors: DS Postma, Guy Brusselle, A Bush, JW Holloway
Pages: 88 - 89 - Blood eosinophils and smoking history affect outcome with high dose N-acetylcysteine treatment in COPD(2017)Volume: 50
Authors: Alberto Papi, Guy Brusselle, Francesco Sergio, Marco Pannacci, Jinping Zheng, Gerard Criner
Number of pages: 1